FDA Allows Marketing Of First Rapid Diagnostic Test For Ebola

By Beth Wang / October 10, 2019 at 5:45 PM
FDA on Thursday (Oct. 10) granted marketing approval for the first time to a rapid diagnostic test that can detect Ebola. The test, FDA said, detects high levels of Ebola virus antigens in human blood in living individuals, as well as in deceased people who are suspected to have died from Ebola. The marketing authorization provides another tool to fight Ebola, which is a top priority for the United States, especially as the U.S. government works with partners to help...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.